RxDoctor Payments Data

Andrew McChesney, MD

Vascular Surgery · Overland Park, KSNPI 1275976458

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $15,333 of the $21,859 with a category attached, or 70.1%. 32 manufacturers reported payments, led by Medtronic at 45.9% of the total. Reporting peaked in 2020 at $7,255 and has fallen 75.0% since, to $1,813 in 2025.

$21,859in general payments, 2019–2025

Across 183 payments — averaging $119.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$10K
  • Endologix LLC$6K
  • Inari Medical, Inc.$958
  • W. L. Gore & Associates, Inc.$559
  • Bolton Medical Inc$533
  • Silk Road Medical, Inc.$491
  • plus $3K from 26 others

What the payments were for

  • Grants$5,83327%
  • Food & beverage$15,33370%
  • Education$6933%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,859 in reported general payments places this provider in the 80th percentile of 22 vascular surgery providers in Kansas.

See all vascular surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$154,411
Medicare patients
452
Services billed
1,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$12,646
ClopidogrelClopidogrel Bisulfate74$720
Atorvastatin Calcium82$613
Cilostazol28$372

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →